...
首页> 外文期刊>Molecules >Hwangryunhaedok-Tang Exerts Neuropreventive Effect on Memory Impairment by Reducing Cholinergic System Dysfunction and Inflammatory Response in a Vascular Dementia Rat Model
【24h】

Hwangryunhaedok-Tang Exerts Neuropreventive Effect on Memory Impairment by Reducing Cholinergic System Dysfunction and Inflammatory Response in a Vascular Dementia Rat Model

机译:Hwangryunhaedok-唐通过降低血管痴呆大鼠模型中的胆碱能系统功能障碍和炎症反应来对记忆损伤发挥神经预审障碍的影响

获取原文
获取原文并翻译 | 示例

摘要

Hwangryunhaedok-tang (HRT) is a traditional oriental herbal formula used in Asian countries for treating inflammatory diseases and controlling fever. Our present study aimed to determine whether HRT has therapeutic effects for patients with vascular dementia (VaD) using a bilateral common carotid artery occlusion (BCCAO) rat model and assessing spatial memory impairment and activation of neuroinflammation. BCCAO was performed in male Sprague Dawley rats to induce VaD, and oral HRT was administered daily for 30 d. Our data showed that HRT ameliorated BCCAO-induced memory and cognitive impairment in behavioral tests. In addition, HRT reversed cholinergic dysfunction and neuronal damage in the hippocampus of BCCAO rats. Furthermore, HRT attenuated microglial activation and reduced the phosphorylation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK) induced by BCCAO. Simultaneous high-performance liquid chromatography analysis of HRT using index compounds from the herbal composition revealed that both HRT ethanol extract and commercial HRT granules primarily comprise geniposide, baicalin, and berberine. Our study showed that HRT administration resulted in the prevention of neuronal injury induced by BCCAO through improvement of cholinergic dysfunction and inhibition of neuroinflammatory responses, suggesting that HRT may have potential as a treatment for VaD.
机译:HwangryunhaeDok-Tang(HRT)是亚洲国家使用的传统东方草药配方,用于治疗炎症性疾病和控制发烧。我们目前的研究旨在确定HRT对血管痴呆(VAD)患者使用双侧常见的颈动脉闭塞(BCCAO)大鼠模型以及评估空间记忆障碍和神经炎症激活的患者对血管痴呆(VAD)的治疗效果。 BCCAO在雄性Sprague Dawley大鼠中进行以诱导VAD,每天施用口服HRT 30天。我们的数据显示,HRT改善了BCCAO引起的内存和行为测试中的认知障碍。此外,HCRT逆转胆碱能功能障碍和BCCAO大鼠海马的神经元损伤。此外,HCRT减毒的微胶质激活并降低了BCCAO诱导的P38丝裂原激活蛋白激酶和C-JUN N-末端激酶(JNK)的磷酸化。使用来自草药组合物的指数化合物的HRT的同时高效液相色谱分析显示,HRT乙醇提取物和商业HRT颗粒主要包括栀子,黄芩苷和小檗碱。我们的研究表明,HRT给药导致BCCAO通过改善胆碱能功能障碍和神经炎炎症反应的抑制来预防受BCCAO的神经元损伤,表明HRT可能具有作为VAD的处理的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号